Bezafibrate for the Secondary Prevention of Myocardial Infarction in Patients With Metabolic Syndrome

Abstract
Research from JAMA Internal Medicine — Bezafibrate for the Secondary Prevention of Myocardial Infarction in Patients With Metabolic Syndrome